In support of the latter hypothesis, ZEB1 knock‐out in the mouse model of pancreatic cancer reduces the metastatic burden to about 30% without affecting the expression of Snail1 or other EMT‐TFs (Krebs et al., 2017). The gene discussed is ZEB1; the disease is pancreatic neoplasm.